Kukje Pharma Co., Ltd. (KRX:002720)
4,870.00
+85.00 (1.78%)
Apr 1, 2026, 3:30 PM KST
Kukje Pharma Revenue
In the year 2025, Kukje Pharma had annual revenue of 175.50B KRW with 12.16% growth. Kukje Pharma had revenue of 43.34B in the quarter ending December 31, 2025, with 4.09% growth.
Revenue
175.50B
Revenue Growth
+12.16%
P/S Ratio
0.57
Revenue / Employee
707.65M
Employees
248
Market Cap
99.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 175.50B | 19.03B | 12.16% |
| Dec 31, 2024 | 156.46B | 21.09B | 15.58% |
| Dec 31, 2023 | 135.37B | 8.79B | 6.94% |
| Dec 31, 2022 | 126.58B | 6.84B | 5.71% |
| Dec 31, 2021 | 119.75B | -10.65B | -8.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 657.61B |
| Ildong Holdings | 590.89B |
| HANDOK | 535.14B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| Daihan Pharmaceutical | 208.61B |
| MYUNGMOON Pharm co.,Ltd | 193.64B |
| CKD Bio | 159.93B |
| Yuyu Pharma | 139.51B |